Form 4: Vicarious Surgical President Sells Shares for Tax

Sentiment:

Insider Transaction Report


Vicarious Surgical Inc. President Adam Sachs sold 463 shares of Class A Common Stock to cover tax withholding obligations related to RSU vesting.

Summary

  • Adam Sachs, President, Director, and 10% Owner of Vicarious Surgical Inc. (RBOT), sold 463 shares of Class A Common Stock.
  • The transaction occurred on December 3, 2025, at a weighted average price of $2.952 per share, with individual trades ranging from $2.715 to $3.34.
  • The sale was a non-discretionary 'sell to cover' transaction, mandated by the company's equity incentive plan to satisfy tax withholding obligations from the vesting of restricted stock units (RSUs) granted on June 2, 2023.
  • Following the transaction, Adam Sachs directly beneficially owns 47,885 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary 'sell to cover' for tax purposes following RSU vesting, which is a neutral event for market sentiment. It does not indicate a change in management's view of the company's prospects.

Positives

  • The underlying event was the vesting of restricted stock units (RSUs), indicating compensation for the executive.

Future Outlook

No forward-looking statements or guidance were provided in this Form 4 filing.

Management Comments

  • The sales reported were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.
  • The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

This Form 4 filing reports a routine insider transaction (sell-to-cover) and does not provide information relevant to broader industry trends or competitive analysis.

Comparison to Industry Standards

  • This filing details a standard 'sell to cover' transaction for tax purposes, which is a common practice across publicly traded companies when restricted stock units vest. It does not contain information suitable for comparison to specific company or project performance benchmarks.

Stakeholder Impact

  • Shareholders: The sale of a small number of shares by an insider for tax purposes is generally not considered a significant event for shareholders, as it is non-discretionary and does not reflect a change in investment conviction.
  • Employees: The vesting of RSUs and subsequent tax-related sale is a standard component of executive compensation plans.

Next Steps

  • The Reporting Person undertakes to provide full information about the number of shares sold at each separate price upon request to the SEC, Vicarious Surgical Inc., or any security holder.

Key Dates

DateDescription
June 2, 2023Grant date of restricted stock units (RSUs) to Adam Sachs.
December 3, 2025Date of transaction where Adam Sachs sold shares.
December 4, 2025Date the Form 4 was signed by Attorney-in-Fact Sarah Romano.

Recommendation

hold

This Form 4 filing reports a routine, non-discretionary 'sell to cover' transaction by an insider to satisfy tax obligations upon RSU vesting. Such transactions are common and do not typically signal a change in the company's fundamentals or the insider's long-term view. Therefore, it provides no new information that would warrant a change in an existing investment thesis, leading to a 'hold' recommendation based solely on this filing.

Keywords

Vicarious Surgical, RBOT, Adam Sachs, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, Tax Withholding, Sell to Cover, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.